PetMed Express, Inc.
PETS
$4.19
$0.020.48%
Weiss Ratings | PETS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Weak | |||
Risk Index | Weak | |||
Risk Grade | D- | |||
Reward Grade | D+ | |||
Rating Factors | PETS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Very Weak | |||
Efficiency Index | Good | |||
Solvency Index | Excellent | |||
Total Return Index | Very Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | PETS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.51 | |||
Price History | PETS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -6.68% | |||
30-Day Total Return | -15.69% | |||
60-Day Total Return | -27.13% | |||
90-Day Total Return | 8.83% | |||
Year to Date Total Return | -9.70% | |||
1-Year Total Return | -16.37% | |||
2-Year Total Return | -75.23% | |||
3-Year Total Return | -82.84% | |||
5-Year Total Return | -81.69% | |||
52-Week High % Change | -39.12% | |||
52-Week Low % Change | 43.79% | |||
Price | PETS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $6.85 | |||
52-Week Low Price | $2.90 | |||
52-Week Low Price (Date) | Aug 13, 2024 | |||
52-Week High Price (Date) | Dec 09, 2024 | |||
Valuation | PETS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 86.02M | |||
Enterprise Value | 37.03M | |||
Price/Earnings (TTM) | 672.58 | |||
Earnings Per Share (TTM) | 0.01 | |||
Earnings Per Share Growth | -104.41% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 0.35 | |||
Price/Book (Q) | 0.89 | |||
Enterprise Value/Revenue (TTM) | 0.15 | |||
Price | $4.19 | |||
Enterprise Value/EBITDA (TTM) | 4.53 | |||
Enterprise Value/EBIT | 15.97 | |||
Market Cap Category | Micro Cap | |||
Dividends and Shares | PETS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 20.63M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | $0.30 | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | 54.34% | |||
Dividend Per Share (Most Recent) | $0.30 | |||
Company Info | PETS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 561 526 4444 | |||
Address | 420 South Congress Avenue Delray Beach, FL 33445 | |||
Website | www.1800petmeds.com | |||
Country | United States | |||
Year Founded | 1996 | |||
Profitability | PETS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 0.93% | |||
Profit Margin | 0.14% | |||
Management Effectiveness | PETS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 0.91% | |||
Return on Equity | 0.36% | |||
Income Statement | PETS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 247.01M | |||
Total Revenue (TTM) | 247.01M | |||
Revenue Per Share | $11.97 | |||
Gross Profit (TTM) | 68.37M | |||
EBITDA (TTM) | 8.18M | |||
EBIT (TTM) | 2.32M | |||
Net Income (TTM) | 357.00K | |||
Net Income Avl. to Common (TTM) | 357.00K | |||
Total Revenue Growth (Q YOY) | -18.88% | |||
Earnings Growth (Q YOY) | 65.12% | |||
EPS Diluted (TTM) | 0.01 | |||
EPS Diluted Growth (Q YOY) | 65.70% | |||
Balance Sheet | PETS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 50.10M | |||
Cash Per Share (Q) | $2.43 | |||
Total Current Assets (Q) | 68.38M | |||
Total Preferred Equity (Q) | 0.01 | |||
Total Equity (Q) | 96.18M | |||
Current Ratio (Q) | 1.426 | |||
Book Value Per Share (Q) | $4.66 | |||
Total Assets (Q) | 144.80M | |||
Total Current Liabilities (Q) | 47.96M | |||
Total Debt (Q) | 1.11M | |||
Total Liabilities (Q) | 48.61M | |||
Total Common Equity (Q) | 96.18M | |||
Cash Flow | PETS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -3.98M | |||
Cash from Financing (TTM) | -194.00K | |||
Net Change in Cash (TTM) | 661.00K | |||
Levered Free Cash Flow (TTM) | 2.26M | |||
Cash from Operations (TTM) | 4.83M | |||